Search
forResearch 10 of 1000+
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- Expanding the Cutaneous Spectrum of Nicolaides‑Baraitser Syndrome: Eczema and Generalized Hair Loss
- H11 More cancer, better counting or better at diagnosis? The history of skin cancer registration
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- The BIOMarkers in Atopic Dermatitis and Psoriasis (BIOMAP) glossary: developing a lingua franca to facilitate data harmonization and cross‐cohort analyses
- Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.
- Registrars’ Symposium: Summaries of Papers
Community 3 of 23
- ‘Long term use of fin/dut may be associated with health risks including fatty liver disease, insulin resistance, type 2 diabetes, dry eye disease and potential kidney disease.’
- Pattern hair loss before the age of 35 is associated with higher chances of prostate cancer, cardiovascular diseases, and metabolic syndrome later in life
- Androgenetic alopecia is a skin disease: DHT-mediated skin disorders
Learn
— no results
Try a deeper search in learn →